W STRATEGIES, LLC

Lobbying for ABBVIE INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Education and legislation related to reform of the 340(b) program. Education around data privacy.

Medicare/Medicaid

Medicare Implementation of the Inflation Reduction Act. Public Law 119-21: One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.